Clinical Trial

LUPKYNIS Drug-use Results Survey

Name: LUPKYNIS Drug-use Results Survey — clinical trial record (NCT07053891)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to survey the safety of LUPKYNIS in patients with lupus nephritis under actual use conditions. In addition, information on efficacy will be collected.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-06-27; most recent amendment 2025-09-18.

Status change: Not Yet Recruiting → Recruiting 2025-07-07

Trial Details

NCT Number	NCT07053891
Lead Sponsor	Otsuka Pharmaceutical Co., Ltd.
Conditions	Lupus Nephritis
Enrollment	400 participants
Start Date	2025-09-17
Primary Completion	2031-06-30 (estimated)
Study Completion	2032-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-09-19